SCHEMBL19768271

SCHEMBL19768271

c1ccc(-c2ccc3ccc4ccc(-c5cccc(-c6ccc7c8ccccc8c8ccccc8c7c6)c5)nc4c3n2)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.45
LMNA P02545 4/20 0.45
TP53 P04637 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
CCR1 P32246 3/20 0.45
CCR5 P51681 3/20 0.45
CCR8 P51685 3/20 0.45
ALOX15 P16050 2/20 0.45
HTT P42858 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
ALPL P05186 1/20 0.45
HSP90AA1 P07900 1/20 0.45
ALPI P09923 1/20 0.45
ALPG P10696 1/20 0.45
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
MAP4K4 O95819 1/20 0.38
CYP1A2 P05177 2/20 0.38
POLB P06746 1/20 0.38
METAP1 P53582 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19768304 0.95 DHODH (0.41) KDM4ELMNATP53SMN1; SMN2CCR1
SCHEMBL19768005 0.94 KDM4E (0.51) KDM4ELMNATP53SMN1; SMN2CCR1
SCHEMBL19768101 0.94 KDM4E (0.41) KDM4ELMNATP53SMN1; SMN2CCR1
SCHEMBL19768268 0.92 KDM4E (0.43) KDM4ELMNATP53SMN1; SMN2CCR1
SCHEMBL19768334 0.91 KDM4E (0.40) KDM4ELMNATP53SMN1; SMN2CCR1
SCHEMBL17789420 0.90 CCR1 (0.41) KDM4ELMNATP53SMN1; SMN2CCR1
SCHEMBL13046226 0.89 KDM4E (0.40) KDM4ELMNATP53SMN1; SMN2CCR1
SCHEMBL19768059 0.89 DHODH (0.45) KDM4ELMNATP53SMN1; SMN2CCR1
SCHEMBL21755627 0.89 KDM4E (0.55) KDM4ELMNATP53SMN1; SMN2CCR1
SCHEMBL16303787 0.88 CCR1 (0.44) KDM4ELMNATP53SMN1; SMN2CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT TORAY INDUSTRIES, INC (JP) 2018-01-18 US disclosed
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT TORAY INDUSTRIES, INC (JP) 2018-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT SUN2, PAH, FARS2 KDM4E 488/4885LMNA 668/4885TP53 3455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.